Revax.cn - REGiMMUNE Announces Collaboration with JDRF and Pfizer …

Provided by Alexa ranking, revax.cn has ranked N/A in N/A and 1,229,112 on the world. revax.cn reaches roughly 2,544 users per day and delivers about 76,321 users each month. The domain revax.cn uses a Commercial suffix and it's server(s) are located in N/A with the IP number 103.71.239.72 and it is a .cn domain.

WEBApr 14, 2015 · The company’s proprietary platform technology, reVax, induces immune tolerance in an antigenspecific manner through pharmacological induction of regulatory T (Treg) cells. Using its reVax technology, REGiMMUNE is developing RGI-2001, which may be the first drug in the class of Treg-inducing agents.

List of domain same IP 103.71.239.72

Search Results related to revax.cn on Search Engine

REGiMMUNE Announces Collaboration with JDRF and Pfizer …
pfizer.com

https://www.pfizer.com/news/press-release/press-release-detail/regimmune-announces-collaboration-jdrf-and-pfizer-inc-type

WEBApr 14, 2015 · The company’s proprietary platform technology, reVax, induces immune tolerance in an antigenspecific manner through pharmacological induction of regulatory T (Treg) cells. Using its reVax technology, REGiMMUNE is developing RGI-2001, which may be the first drug in the class of Treg-inducing agents.

DA: 83 PA: 1 MOZ Rank: 82

REVAXIS suspension for injection in pre-filled syringe
medicines.org.uk

https://www.medicines.org.uk/emc/product/5581/smpc

WEBPosology. The dose for children from the age of six years, adolescents and adults is 0.5 ml. REVAXIS should be administered in accordance with official recommendations and/or local practice regarding the use of vaccines that provide reduced dose diphtheria toxoid plus tetanus toxoid in combination with inactivated poliomyelitis viruses.

DA: 22 PA: 84 MOZ Rank: 69

Revax Biotech Ultra-Low Dose Vaccine Technology can make …
pharmiweb.com

https://www.pharmiweb.com/press-release/2021-10-06/revax-biotech-ultra-low-dose-vaccine-technology-can-make-world-vaccination-a-reality

WEBOct 6, 2021 · Revax Biotech Ultra-Low Dose Vaccine Technology can make World Vaccination a Reality. Revax Biotech announce their response to the G7/WHO Challenge enabling vaccines to be available to meet existing or emerging respiratory pandemic threats in 100 days or less.

DA: 42 PA: 33 MOZ Rank: 26

Revax Biotech Ltd | LinkedIn
linkedin.com

https://www.linkedin.com/company/revax-biotech-ltd

WEBAbout us. Helping to make a reality of the G7 100 day Mission to reduce the impact of future pandemics by making Vaccines available within 100 days. Website. http://www.revaxbiotech.com. Industry....

DA: 52 PA: 59 MOZ Rank: 69

Clinical Development of New TB Vaccines: Recent Advances and …
nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7002896/

WEBJan 30, 2020 · The BCG REVAX trial will aim to replicate the efficacy signal against sustained Mtb infection with greater precision; assess durability of protection through 4 years after vaccination; and discover and validate immune correlates of …

DA: 78 PA: 58 MOZ Rank: 48

BCG Re-vaccination
nationalacademies.org

https://www.nationalacademies.org/documents/embed/link/LF2255DA3DD1C41C0A42D3BEF0989ACAECE3053A6A9B/file/D354003917608414355C85BCC2124D4F37DAD0B02B58?noSaveAs=1

WEBBCG vaccine from AJ Vaccines / Biovac Institute (Danish 1331) Approx.1,800 IGRA-negative participants 10-18 years of age. IGRA every 6 months for 48 months, plus 2 post-conversion visits. Primary objective: • Demonstrate the efficacy of BCG revaccination for the prevention of sustained Mtb infection (POSI) / Event-triggered analysis once 118 ...

DA: 95 PA: 75 MOZ Rank: 44

Recent advance in the development of tuberculosis vaccines in …
nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10652786/

WEBNov 2, 2023 · To generate data that can potentially support policy change for BCG (revaccination), the Gates MRI BCG ReVax trial was conducted and AJVaccines’ BCG (Danish 1331) was compared with saline placebo for the prevention of sustained IGRA conversion (initial conversion and IGRA-positive 3 and 6 …

DA: 74 PA: 34 MOZ Rank: 37

Frontiers | Cheap and Commonplace: Making the Case for BCG …
frontiersin.org

https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2021.743924/full

WEBSep 7, 2021 · The REVAX clinical trial is ongoing to assess whether revaccination of adolescence may be a useful tool for TB control. After BCG was introduced in the 1920s, epidemiological studies reported that BCG vaccination greatly reduced infant mortality, beyond that which could be explained by a reduction in TB alone ( 9 ).

DA: 36 PA: 2 MOZ Rank: 84

Implant retention systems for implant-retained overdentures
nature.com

https://www.nature.com/articles/sj.bdj.2017.215

WEBMar 10, 2017 · The Ceka Revax system is a slightly different system whereby the male component is within the prosthesis. This is a spring pin system which attaches exactly into a conical female component.

DA: 8 PA: 10 MOZ Rank: 24

Rev Max FAQ – Rev.com Help Center
rev.com

https://support.rev.com/hc/en-us/articles/8047649891853-Rev-Max-FAQ

WEBFeb 1, 2024 · Simple and cost-effective solution that speaks to your needs – less expensive and easier workflow than placing recurring pay-as-you-go orders. $29.99/month for 20 hours/month (vs. $0.25/minute) 5% off Human Transcription, Captions, and Subtitles. 1 workspace. New Pro Plan features. $59.99/month for 40/hours/month.

DA: 11 PA: 85 MOZ Rank: 18

Alexa Rank

GLOBAL RANK

1,229,112

Alexa Reach

0.0001123040

Page length

N/A

Alexa Rank Country N/A

N/A

Daily Unique Visitors

2,544

Monthly Unique Visitors

76,321

Vistor via Country

Country lang

Country code

Total visitor

Country

Country code

Total visitor

United States

16,325

Indonesia

12,769

Taiwan

4,152

United Kingdom

3,686

Brazil

3,335

Nigeria

2,915

Egypt

2,450

Hong Kong

2,313

Canada

2,313

Australia

2,015

Philippines

1,442

India

1,404

Malaysia

1,381

Spain

1,145

Germany

1,114

Mexico

1,068

France

1,007

Italy

931

Turkey

855

Iraq

778

Thailand

763

Netherlands

733

Israel

725

Cambodia

603

Algeria

466

Ireland

420

Romania

405

Jordan

374

Poland

359

Ghana

343

Argentina

328

South Africa

298

Belgium

267

Czechia

244

Ukraine

229

Japan

229

Morocco

221

South Korea

214

Lebanon

206

Saudi Arabia

198

Austria

191

Hungary

183

Sweden

176

Singapore

168

Pakistan

160

Bangladesh

153

Denmark

145

Greece

137

Alexa Traffic Graph

Alexa daily traffic trend graph

Alexa daily pageviews (percent) graph

Alexa Statistics Graph for www.nahklick.de

Alexa daily pageviews per user graph

Alexa time on site (in minutes) graph

Alexa bounce rate (percent) graph

Alexa search visits graph

SEOquake Zone

Title			Tips
Description			Tips
Keywords			Tips
Viewport			Tips
Icon
UTF-8

Mini site formation by Alexa Rank

MOZ Rank

DNS Record

Host	Type	Class	TTL	Extra
revax.cn	HINFO	IN	3600	Cpu: RFC8482 Os:

Hosting and Whois Zone

IP	103.71.239.72
Domain infomation	Domain Name: revax.cn ROID: 20070614s10001s87312487-cn Domain Status: ok Registrant: 温州瑞阳光伏材料有限公司 Registrant Contact Email: [email protected] Sponsoring Registrar: 阿里云计算有限公司（万网） Name Server: dns15.hichina.com Name Server: dns16.hichina.com Registration Time: 2007-06-14 10:42:12 Expiration Time: 2025-06-14 10:42:12 DNSSEC: unsigned